Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
São Paulo med. j ; 141(2): 114-119, Mar.-Apr. 2023. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1424669

ABSTRACT

ABSTRACT BACKGROUND: The Hip Sports Activity Scale (HSAS) is a hip-specific instrument for assessing the present levels of physical activity among patients with femoroacetabular impingement (FAI) syndrome. When evaluating treatment outcomes in patients with FAI syndrome, it is necessary to use joint-specific instruments and ones that can evaluate the levels of physical activity in these patients, such as the HSAS-Brazil. OBJECTIVE: To validate the HSAS-Brazil among a group of physically active patients after arthroscopic treatment of FAI syndrome. DESIGN AND SETTING: Cross-sectional research of quantitative and qualitative types using data obtained from July 2018 to October 2019. METHODS: A total of 58 patients of both genders diagnosed with FAI syndrome and who had undergone hip arthroscopy participated in this research. To establish reliability and validity, patients first answered the Brazilian versions of the 12-Item Short-Form Health Survey (SF-12), Nonarthritic Hip Score (NAHS), and HSAS; after a 48-hour interval, they answered the HSAS-Brazil again. RESULTS: For test-retest reliability, the interclass correlation was 0.908 (P < 0.001). The HSAS-Brazil correlated to the NAHS-Brazil (r = 0.63, P < 0.001), as well as the SF-12 (Physical Health) (r = 0.42, P = 0.001). CONCLUSION: The HSAS-Brazil was validated and proved to be a reliable and valid scale to assess sports activity levels in physically active patients with FAI syndrome after arthroscopic treatment.

2.
Philippine Journal of Allied Health Sciences ; (2): 36-41, 2022.
Article in English | WPRIM | ID: wpr-962438

ABSTRACT

BACKGROUND@#With the COVID-19 pandemic, the need for social distancing presents an apparent barrier to in-clinic consultation. Therefore, the adoption of telerehabilitation has rapidly increased to improve access and minimize cross-infection risk to patients. Nevertheless, Filipino pediatric physical therapists must ensure that they conduct evidence-based procedures for specific tests and measures to determine patient outcomes. The utilization of outcome measurement tools (OMTs) enhances the quality of assessment in clinical decision-making and provides a credible and reliable justification for treatment on an individual patient level. However, a lack of information on utilizing OMTs in telerehabilitation by pediatric physical therapists internationally and locally is evident@*OBJECTIVE@#To determine the most common pediatric OMTs used in telerehabilitation by Filipino pediatric physical therapists catering to 0 to 21-year-olds in the Philippines.@*METHODS@#The study will use an adapted questionnaire to gather data on common OMTs used during pediatric telerehabilitation. Phase I will include the validation of the 15-item adapted questionnaire by determining the content validity index. In Phase II, participants will be recruited through email and social media. Descriptive statistics will be used to report participants' responses@*EXPECTED RESULTS@#In Phase I, the expected result is a valid and reliable questionnaire to investigate the common OMTs used in pediatric telerehabilitation for Phase II. The results will be synthesized to inform other researchers and clinicians and encourage nonusers to utilize OMTs despite the challenge of the pandemic. The study can give insights to stakeholders on what OMTs optimize pediatric telerehabilitation.

3.
Epidemiology and Health ; : e2016013-2016.
Article in English | WPRIM | ID: wpr-721335

ABSTRACT

Latent class analysis (LCA) is a method of assessing and correcting measurement error in surveys. The local independence assumption in LCA assumes that indicators are independent from each other condition on the latent variable. Violation of this assumption leads to unreliable results. We explored this issue by using LCA to estimate the prevalence of illicit drug use in the Iranian Mental Health Survey. The following three indicators were included in the LCA models: five or more instances of using any illicit drug in the past 12 months (indicator A), any use of any illicit drug in the past 12 months (indicator B), and the self-perceived need of treatment services or having received treatment for a substance use disorder in the past 12 months (indicator C). Gender was also used in all LCA models as a grouping variable. One LCA model using indicators A and B, as well as 10 different LCA models using indicators A, B, and C, were fitted to the data. The three models that had the best fit to the data included the following correlations between indicators: (AC and AB), (AC), and (AC, BC, and AB). The estimated prevalence of illicit drug use based on these three models was 28.9%, 6.2% and 42.2%, respectively. None of these models completely controlled for violation of the local independence assumption. In order to perform unbiased estimations using the LCA approach, the factors violating the local independence assumption (behaviorally correlated error, bivocality, and latent heterogeneity) should be completely taken into account in all models using well-known methods.


Subject(s)
Bias , Mental Health , Methods , Prevalence , Self Report , Substance-Related Disorders , Surveys and Questionnaires
4.
Rev. bras. med. esporte ; 19(5): 359-362, set.-out. 2013. graf, tab
Article in Portuguese | LILACS | ID: lil-696053

ABSTRACT

OBJETIVO: Propor um método de familiarização individualizado para saltos verticais e verificar o seu efeito na variabilidade intrassujeito. MÉTODOS: Cinquenta e três homes (média ± DP; idade 23,5 ± 3,3 anos; estatura 1,76 ± 0,08 m; massa 72,8 ± 8,6 kg; percentual de gordura 12,9 ± 5,2%) realizaram sucessivos saltos até atingir o nível de estabilidade proposto. Após 48 h este processo era repetido e a estabilidade entre dias era verificada, se necessário, mais sessões eram realizadas. O nível de estabilidade foi determinado por um teste z, com intervalo de confiança de 95%. Após o processo de familiarização, duas sessões experimentais adicionais foram realizadas para determinar a confiabilidade do desempenho no salto agachado (SA) e no salto com contramovimento (SCM). O coeficiente de variação e o erro padrão de medida foram determinados individualmente (CVi e EPMi). Um teste t pareado foi realizado para verificar diferenças no CVi e EPMi antes e depois do processo de familiarização. RESULTADOS: O CVi apresentou uma redução significativa após o processo de familiarização (p < 0,001), alterando de 5,01 ± 2,40% para 2,95 ± 0,89% no SA e de 4,50 ± 2,19% para 2,58 ± 0,81% no SCM. O mesmo ocorreu para o EPMi variando de 1,29± 0,53 cm para 0,83 ± 0,25 cm no SA e de 1,35 ± 0,51 cm para 0,83 ± 0,26 cm no SCM. CONCLUSÃO: o método de familiarização individualizado proposto reduziu significativamente a variação intrassujeito, permitindo maior poder estatístico em estudos experimentais e maior sensibilidade para ferramentas de monitoramento do desempenho.


OBJECTIVE: The aim of the present study was to propose an individualized familiarization method for vertical jumps and to verify its effect on intra-subject variability. METHODS: Fifty three men (mean ± S.D.; age 23.5 ± 3.3; height 1.76 ± 0.08 m; mass 72.8 ± 8.6 Kg; body fat 12.9 ± 5.2%) performed successive jumps to reach the proposed stability level. After 48 hours, this process was repeated and the stability between the days was verified; if necessary, more sessions were performed. The stability level was determined by a Z-Test with a confidence interval of 95%. After the familiarization process, two additional experimental sessions were performed in order to determine the reliability of the performance in the Squat Jump (SJ) and the Countermovement Jump (CMJ). The coefficient of variation and standard error of measurement were determined individually (CVi and SEMi). A paired T-Test was performed to verify differences in the CVi and SEMi before and after the familiarization process. RESULTS: The CVi presented a significant reduction after the familiarization process (p < 0.001), changing from 5.01 ± 2.40% to 2.95 ± 0.89% in the SJ. The CVi also changed in the CMJ (from 4.50 ± 2.19% to 2.58 ± 0.81%). The same also occurred with the SEMi in both the SJ and the CMJ, changing from 1.29 ± 0.53 cm to 0.83 ± 0.25 cm in the SJ and from 1.35 ± 0.51cm to 0.83 ± 0.26 cm in the CMJ. CONCLUSION: The proposed individualized familiarization method significantly decreased intra-subject variability, which allows for a higher statistical power in the laboratorial setting and a greater sensitivity for performance monitoring tools.

5.
Journal of the Korean Academy of Rehabilitation Medicine ; : 503-511, 2007.
Article in Korean | WPRIM | ID: wpr-724417

ABSTRACT

OBJECTIVE: To investigate which outcome measurements are useful for detecting functional changes after therapeutic approach to delayed motor impairment in an animal model of Huntington's disease (HD). METHOD: R6/2 transgenic mice received intraventricular injections of adenoviral BDNF/noggin (AdB/N), AdBDNF, AdNull (n=15 each) at 4 weeks of age. Untreated R6/2s and wild-type mice were also recruited as controls. Motor performance was measured using rotarod analysis and locomotor activity test at regular intervals until preterminal age of 13 weeks. RESULTS: On constant speed rotarod testing, AdB/N-treated R6/2s exhibited a delayed disease progression after post- operative 6 weeks. AdB/N also ameliorated general locomotor activity deficits. One min-rotarod analysis showed a delayed motor impairment in AdBDNF group at preterminal age compared with AdNull and untreated controls, which was not shown in 3 min and 5 min-rotarod. Accelerating rotarod paradigm was not superior to constant speed. Partial therapeutic effects on locomotor activities were detected in total 60 min-monitoring, but not in 30 min- or 10 min- monitoring. CONCLUSION: Appropriate behavioral testing and outcome measurements should be selected to detect the treatment effect to slow functional deterioration in HD.


Subject(s)
Animals , Mice , Disease Progression , Huntington Disease , Injections, Intraventricular , Mice, Transgenic , Models, Animal , Motor Activity , Rotarod Performance Test
6.
Journal of Korean Neurosurgical Society ; : 581-585, 2001.
Article in Korean | WPRIM | ID: wpr-77323

ABSTRACT

OBJECTIVES: Criteria for evaluating the results of treating low back pain vary widely. We examined the methods measuring the outcome in the papers of Journal of Korean Neurosurgical Society. METHODS: We selected all published articles describing the methods measuring the outcome of low back pain in the journal. They were classified into 3 periods such as period 1 for volume 1-20, 2 for volume 21-25, and 3 for volume 26-28. RESULTS: There are 25 articles in period 1, 44 in period 2, and 30 in period 3. The outcome was classified into 0 to 5 classes by more than 15 different methods. Although the terms and descriptive criteria differ, 4 classes were the most common classification, being 16 in period 1, 39 in period 2, and 19 in period 3. The outcome was usually measured by authors' own method in period 1. In period 2, criteria by Gill et al was most commonly used along with many different criteria. Criteria by Prolo et al became a common method in period 3. CONCLUSION: Varying methods compromised comparative analyses of outcome. A more simple and universally applicable criteria is necessary to facilitate comparisons among various methods of treatment.


Subject(s)
Animals , Humans , Classification , Gills , Low Back Pain , Spine
7.
Japanese Journal of Pharmacoepidemiology ; : 37-48, 2001.
Article in Japanese | WPRIM | ID: wpr-376067

ABSTRACT

The necessity of the methodology to manage and objectively evaluate outcomes is recognized for practicing cost-effective quality care. When outcome management is applied to pharmaceutical therapy, it is important to understand the relationship between outcome management and pharmacoeconomics. Pharmacoeconomics is a tool not only to evaluate the economical efficiency of pharmaceuticals themselves but also to evaluate the efficiency of clinical pharmaceutical interventions by medical staff. To apply outcome management and pharmacoeconomics in practice, it is necessary to systemize the contents of pharmaceutical care linkied to related outcomes and to continuously document the required information for the analysis and evaluation of outcomes.

SELECTION OF CITATIONS
SEARCH DETAIL